Clinical Trial of SARS-CoV-2 mRNA Vaccine in China
Clinical trial NCT05364047 · UNKNOWN
Trial details
- NCT number
- NCT05364047
- Sponsor
- AIM Vaccine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-31
- Primary completion
- 2022-10-14
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.